NASDAQ
8.29USD
+0.30 (+3.75%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
270.1M
P/E
—
EPS
—
Beta
3.38
52W range
4.5-10.062
Day range
7.96–8.48
Open
8.00
Prev close
7.99
Volume
535.1K
Avg volume
1M
Dividend
0.00
IPO
2023-07-14
https://seekingalpha.com/article/4930654-sagimet-stock-look-earnings-ahead-catalyst-heavy-2h26 · 8/5/2026+0.80
https://www.zacks.com/stock/news/2914837/does-sagimet-biosciences-inc-sgmt-have-the-potential-to-rally-241-77-as-wall-street-analysts-expect?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2914837 · 5/5/2026+1.00
https://www.globenewswire.com/news-release/2025/10/07/3162363/0/en/Sagimet-Biosciences-Announces-Upcoming-Presentation-at-AASLD-The-Liver-Meeting-2025.html · 10/7/2025+0.80
https://seekingalpha.com/article/4819912-sagimet-biosciences-inc-sgmt-presents-at-cantor-global-healthcare-conference-2025-transcript · 9/8/2025+0.00
https://www.globenewswire.com/news-release/2025/08/26/3139126/0/en/Sagimet-Biosciences-to-Participate-in-Two-Upcoming-Investor-Conferences.html · 8/26/2025+0.60
https://www.globenewswire.com/news-release/2025/08/13/3132474/0/en/Sagimet-Biosciences-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates.html · 8/13/2025+0.80
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
